Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Papasavvas

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|July 26, 2018
Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIVEmmanouil Papasavvas, Steven M Lada, Jocelin Joseph, et al.
AIDS (London, England)|October 23, 2003
Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patientsEmmanouil Papasavvas, Robert M Grant, Junwei Sun, et al.
AIDS (London, England)|June 6, 2008
Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapyEmmanouil Papasavvas, Livio Azzoni, Maxwell Pistilli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytesEmmanouil Papasavvas, Junwei Sun, Qi Luo, et al.
Frontiers in Immunology|March 8, 2019
Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK SignalingFlorent Colomb, Leila B Giron, Thomas A Premeaux, et al.
AIDS (London, England)|May 28, 2021
Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruptionEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
Journal of the International AIDS Society|August 2, 2011
Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyLivio Azzoni, Andrea S Foulkes, Cynthia Firnhaber, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodiesEmmanouil Papasavvas, Lily Lu, Matthew Fair, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2024
Cloning and Functional Characterization of Novel Human Neutralizing Anti-IFN-α and Anti-IFN-β AntibodiesEmmanouil Papasavvas, Lily Lu, Matthew Fair, et al.
Immunity|August 22, 2025
Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistenceYulong Wei, Haocong Katherine Ma, Michelle E Wong, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|July 26, 2018
Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIVEmmanouil Papasavvas, Steven M Lada, Jocelin Joseph, et al.
AIDS (London, England)|October 23, 2003
Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patientsEmmanouil Papasavvas, Robert M Grant, Junwei Sun, et al.
AIDS (London, England)|June 6, 2008
Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapyEmmanouil Papasavvas, Livio Azzoni, Maxwell Pistilli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytesEmmanouil Papasavvas, Junwei Sun, Qi Luo, et al.
Frontiers in Immunology|March 8, 2019
Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK SignalingFlorent Colomb, Leila B Giron, Thomas A Premeaux, et al.
AIDS (London, England)|May 28, 2021
Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruptionEmmanouil Papasavvas, Livio Azzoni, Brian N Ross, et al.
Journal of the International AIDS Society|August 2, 2011
Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyLivio Azzoni, Andrea S Foulkes, Cynthia Firnhaber, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodiesEmmanouil Papasavvas, Lily Lu, Matthew Fair, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2024
Cloning and Functional Characterization of Novel Human Neutralizing Anti-IFN-α and Anti-IFN-β AntibodiesEmmanouil Papasavvas, Lily Lu, Matthew Fair, et al.
Immunity|August 22, 2025
Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistenceYulong Wei, Haocong Katherine Ma, Michelle E Wong, et al.
Pageof 6